AM Best Assigns Credit Ratings to Sabal Specialty Insurance Company, Inc.
AM Best has assigned a Financial Strength Rating of A-(Excellent) and a Long-Term Issuer Credit Rating of “a-” (Excellent) to
The ratings reflect Sabal Specialty’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM).
Sabal Specialty, formed in 2024, is a specialty insurer focused on the
Sabal Specialty was created to provide additional market access to distribution partners by providing a distinct underwriting platform with unique branding. Sabal Specialty will act purely as an underwriting entity, ceding all premiums and losses via a 100% quota share reinsurance agreement to Palms Specialty, generating underwriting income from ceding commissions as opposed to earned premiums. Sabal Specialty is expected to benefit from Palms Specialty’s operational infrastructure, experienced management team and ERM framework, while serving to further diversify the group’s underwriting footprint.
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in
Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251029305964/en/
Financial Analyst
+1 908 882 2467
[email protected]
Associate Director
+1 908 882 1759
[email protected]
Associate Director, Public Relations
+1 908 882 2310
[email protected]
Senior Public Relations Specialist
+1 908 882 2318
[email protected]
Source: AM Best



Reports on COVID-19 Findings from Wright State University Boonshoft School of Medicine Provide New Insights (Childhood Underinsurance in Primary Care: A Practice-Based Study): Coronavirus – COVID-19
Trademark Application for “VERISK” Filed by Insurance Services Office, Inc.: Insurance Services Office Inc.
Advisor News
- Strong underwriting: what it means for insurers and advisors
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
More Advisor NewsAnnuity News
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
- Retirement is increasingly defined by a secure income stream
More Annuity NewsHealth/Employee Benefits News
- Kansas state employees retain choice of Blue Cross, Aetna for health insurance
- CONGRESSWOMAN TENNEY CALLS ON DOJ TO INVESTIGATE NEW YORK'S PLAN TO USE MEDICAID FOR AUTOMATIC VOTER REGISTRATION
- Health insurance legislation signed into law by Reynolds
- Researchers from Virginia Commonwealth University Report on Findings in Substance Abuse (Health insurance type moderates the association between substance use disorders and cardiovascular multimorbidity among U.S. adults – Results from the 2023 …): Addiction Research – Substance Abuse
- New Findings from Fudan University Describe Advances in Beta-Lactam Antibiotics (Budget impact analysis of aztreonam-avibactam for metallo-b-lactamase carbapenem-resistant enterobacterales infections in China): Drugs and Therapies – Beta-Lactam Antibiotics
More Health/Employee Benefits NewsLife Insurance News
- 5 steps to take before selling your firm
- Bismarck man pleads guilty to taking out insurance policy on dead wife
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- U-Haul Holding Company Schedules Fourth Quarter Fiscal Year End 2026 Financial Results Release and Investor Webcast
- New Empathy and LIMRA Research: The Overlooked Opportunity to Engage the Next Generation After an Insurance Payout
More Life Insurance News